Rasheed Omobolaji Alabi, Mohammed Elmusrati, Ilmo Leivo, Alhadi Almangush, Antti A Mäkitie
Artificial Intelligence-Driven Radiomics in Head and Neck Cancer: Current Status and Future Prospects
International journal of medical informatics
review evaluates recent advancements diseasemodifying therapies axial spondyloarthritis axspa recent study could demonstrate additional effect nsaid therapy golimumab tumor necrosis factor inhibitor tnfi structural progression however might due fact study underpowered dmards shown promise suppressing inflammation impact structural progression remains uncertain well powered trial showed difference spinal progression secukinumab interleukin17a inhibitor il17ai adalimumabbiosimilar tnfi preliminary data janus kinase inhibitors jaki focus mri findings lack evidence radiographic spinal progression studies suggest promising outcomes others reveal limitations inconclusive findings recent studies explore effectiveness nsaids biological diseasemodifying antirheumatic drugs like tnfi il17i well jak inhibitors axspa conflicting evidence surrounds therapies ability impede structural progression challenges study design interpretation moreover changes demographics treatment methods underscore importance examining trends time assessing disease outcomes ultimately ongoing research could benefit new imaging tools evaluating therapeutic strategies modifying disease progression axspa